CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics

CytomX Therapeutics, Inc. (CTMX)

Today's Latest Price: $8.12 USD

0.06 (0.74%)

Updated Jun 2 4:00pm

Add CTMX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CTMX Stock Summary

  • CytomX Therapeutics Inc's stock had its IPO on October 8, 2015, making it an older stock than merely 16.12% of US equities in our set.
  • Of note is the ratio of CytomX Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 10.78% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for CytomX Therapeutics Inc is higher than it is for about merely 15.06% of US stocks.
  • Stocks that are quantitatively similar to CTMX, based on their financial statements, market capitalization, and price volatility, are CRUS, SYNA, CRBP, WVE, and MGNX.
  • Visit CTMX's SEC page to see the company's official filings. To visit the company's web site, go to
CTMX Daily Price Range
CTMX 52-Week Price Range

CTMX Stock Price Chart More Charts

CTMX Price/Volume Stats

Current price $8.12 52-week high $15.44
Prev. close $8.06 52-week low $3.60
Day low $7.78 Volume 565,915
Day high $8.18 Avg. volume 551,503
50-day MA $9.31 Dividend yield N/A
200-day MA $7.79 Market Cap 372.89M

CytomX Therapeutics, Inc. (CTMX) Company Bio

CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.

CTMX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CTMX Latest Social Stream

Loading social stream, please wait...

View Full CTMX Social Stream

Latest CTMX News From Around the Web

Below are the latest news stories about CytomX Therapeutics Inc that investors may wish to consider to help them evaluate CTMX as an investment opportunity.

CTMX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 20, 2020 in the Class Action Filed on Behalf of CytomX Therapeutics, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - June 1, 2020) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytomX Therapeutics, Inc. (NASDAQ: CTMX) alleging that the Company violated federal securities laws.Class Period: May 17, 2018 and May 13, 2020Lead Plaintiff Deadline: July 20, 2020Learn more about your recoverable losses in DNK: filed complaint alleges that CytomX Therapeutics, Inc. made materially false and/or misleading statements ...

Yahoo | June 1, 2020

SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 1, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("CytomX" ...

Yahoo | June 1, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMX

New York, New York--(Newsfile Corp. - June 1, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX") between May 17, 2018 and May 13, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the the United States District Court for the Northern District of California. To get more information ...

Yahoo | June 1, 2020

CTMX Shareholder Update: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / June 1, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the ...

Yahoo | June 1, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of LBRT, ZM and CTMX

NEW YORK, NY / ACCESSWIRE / June 1, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. The LBRT Lawsuit is on behalf of investors who purchased securities pursuant and/or traceable to the documents issued in connection with the Company's January 2018 initial public offering.

Yahoo | June 1, 2020

Read More 'CTMX' Stories Here

CTMX Price Returns

1-mo -27.56%
3-mo 12.31%
6-mo 32.46%
1-year -19.60%
3-year -43.22%
5-year N/A
YTD -2.29%
2019 -44.97%
2018 -28.47%
2017 92.08%
2016 -47.34%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8668 seconds.